ROLE OF 3rd, 4th&5th LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER: TREATMENT OUTCOME & TOXICITY IN NEMROCK BETWEEN 2005 & 2010 Retrospective Analysis..
Mohamed Osman Mohamed Elhasan;
Abstract
SUMMARY
Despite advances in screening, locoregional treatment and systemic adjuvant therapy for breast cancer, metastatic relapse is still common. Metanalysis of adjuvant breast cancer trials indicated that after adjuvant polychemotherapy, 40% of patient
Despite advances in screening, locoregional treatment and systemic adjuvant therapy for breast cancer, metastatic relapse is still common. Metanalysis of adjuvant breast cancer trials indicated that after adjuvant polychemotherapy, 40% of patient
Other data
| Title | ROLE OF 3rd, 4th&5th LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER: TREATMENT OUTCOME & TOXICITY IN NEMROCK BETWEEN 2005 & 2010 Retrospective Analysis.. | Other Titles | دور خط العلاج الكيماوى الثالث والرابع والخامس فى علاج حالات سرطان الثدي المنتشر : نتائج العلاج و الاعراض الجانبية. بمركز قصر العينى لعلاج الأورام والطب النووى فى الفترة من (2005-2010 ) . دراسة تحليلية إرتجاعية | Authors | Mohamed Osman Mohamed Elhasan | Keywords | ROLE OF 3rd, 4th&5th LINE CHEMOTHERAPY IN METASTATIC BREAST CANCER: TREATMENT OUTCOME & TOXICITY IN NEMROCK BETWEEN 2005 & 2010 Retrospective Analysis.. | Issue Date | 2012 | Description | SUMMARY Despite advances in screening, locoregional treatment and systemic adjuvant therapy for breast cancer, metastatic relapse is still common. Metanalysis of adjuvant breast cancer trials indicated that after adjuvant polychemotherapy, 40% of patient |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| elresalah.pdf | 1.24 MB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.